Mantlo, US
Bob J. Mantlo, Columbia, MO US
Patent application number | Description | Published |
---|---|---|
20090043641 | PRETRIAL RELEASE SYSTEM AND METHOD - The present invention describes a system and method whereby enhancements are made to an agency pretrial information system by a consortium of service and equipment providers and such enhancements are self funded by means of a electronic custodial fee so as to allow the addition of desired and/or recommended components without necessitating a considerable, or in some instances, any capital investment on the part of the agency. | 02-12-2009 |
John Mantlo, Westminster, MD US
Patent application number | Description | Published |
---|---|---|
20150266928 | METHOD OF PROTEIN EXTRACTION FROM CELLS - Methods for producing a protein extract from cells, such as cells containing viral proteins, are provided. In general terms, the methods involve: increasing the pH of the cells to a pH of at least about pH 10.0 to produce an intermediate composition, and then, in the presence of a non-ionic detergent, neutralizing the pH of the intermediate composition to produce the protein extract. Kits and compositions for practicing the subject methods are also provided. | 09-24-2015 |
John D. Mantlo, Westminster, MD US
Patent application number | Description | Published |
---|---|---|
20150118677 | SAMPLE PREPARATION FOR FLOW CYTOMETRY - Described herein are methods and reagents for identifying and analyzing at least one microorganism (e.g. bacteria) in a sample and reducing the background signal intensity obtained when analyzing the sample by flow cytometry. The sample is prepared by combining the sample with a background signal-reducing molecule or with a nucleic acid stain covalently linked to a quencher. A portion of the particulate matter in the sample can optionally be removed with a resin prior to staining with a nucleic acid stain. | 04-30-2015 |
20150125895 | FORMULATIONS AND PROCESS FOR ISOLATING VIABLE MICROORGANISM FROM POSITIVE BLOOD CULTURES - Various embodiments disclosed herein provide for reagents and methods for rapidly isolating viable microbial cells, including | 05-07-2015 |
Nathan Bryan Mantlo, Brownsburg, IN US
Patent application number | Description | Published |
---|---|---|
20080269284 | Compounds and Methods for Treating Dyslipidemia - Compounds of Formula I wherein n, q, Y, R | 10-30-2008 |
20090054479 | FUSED HETEROCYCLIC DERIVATIVES AS PPAR MODULATORS - The present invention is directed to compounds represented by the following structural formula, Formula I: | 02-26-2009 |
20090062358 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS - The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, | 03-05-2009 |
20090093524 | COMPOUNDS AND METHODS FOR MODULATING FXR - Compounds of formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases. | 04-09-2009 |
20090176863 | THIOPHENE DERIVATIVE PPAR MODULATORS - The present invention is directed to compounds represented by the following structural formula, Formula I: and stereoisomers, pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) X is selected from the group consisting of O, S, S(O)2, N, and a bond; (b) U is an aliphatic linker wherein one carbon atom of the aliphatic linker may be replaced with O, NH or S, and wherein such aliphatic linker is optionally substituted with R30: (c) Y is selected from the group consisting of C, O, S, NH and a single bond; and (d) E is C(R3)(R4)A or A. | 07-09-2009 |
20100099725 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS - The present invention is directed to compounds of the structural Formula: wherein: R | 04-22-2010 |
20100204207 | Compounds and Methods for Treating Dyslipidemia - Compounds of Formula (I): wherein n, m, p, q, Y, R1, R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed. | 08-12-2010 |
20130303471 | NOVEL PYRAZOLE COMPOUNDS - The present invention provides a compound of Formula II: | 11-14-2013 |